相似文献
1
25 years of HIV in New York City: lessons from surveillance.
J Urban Health. 2001 Dec;78(4):669-78. doi: 10.1093/jurban/78.4.669.
2
Economic and geographic diversity in AIDS incidence among HIV exposure groups in New York City: 1983 to 1995.
AIDS Public Policy J. 1998 Fall;13(3):103-14.
3
Pediatric acquired immunodeficiency syndrome: an unusually high incidence of twinning.
Pediatrics. 1990 Nov;86(5):774-7.
4
Trends in the first ten years of AIDS in New York City. The New York City Department of Health AIDS Surveillance Team.
Am J Epidemiol. 1993 Jan 15;137(2):121-33. doi: 10.1093/oxfordjournals.aje.a116652.
5
AIDS surveillance in the Americas.
Epidemiol Bull. 1992 Jul;13(2):15.
6
Implications of the revised surveillance definition: AIDS among New York City drug users.
Am J Public Health. 1992 Nov;82(11):1531-3. doi: 10.2105/ajph.82.11.1531.
7
Trends in the AIDS epidemic among New York City's injection drug users: localized or citywide?
J Urban Health. 2002 Mar;79(1):136-46. doi: 10.1093/jurban/79.1.136.
8
Effect of sexual behavior change on long-term human immunodeficiency virus prevalence among homosexual men.
Am J Epidemiol. 1994 Aug 1;140(3):217-32. doi: 10.1093/oxfordjournals.aje.a117241.
9
Lessons from New York City on HIV/AIDS in adolescents.
N Y State J Med. 1990 Mar;90(3):143-5.
10
HIV/AIDS surveillance in Indiana.
Indiana Med. 1992 Nov-Dec;85(6):486-9.
引用本文的文献
1
Study protocol for data to suppression (D2S): a cluster-randomised, stepped-wedge effectiveness trial of a reporting and capacity-building intervention to improve HIV viral suppression in housing and behavioural health programmes in New York City.
BMJ Open. 2023 Jul 14;13(7):e076716. doi: 10.1136/bmjopen-2023-076716.
2
PROMISE (Program Refinements to Optimize Model Impact and Scalability based on Evidence): a cluster-randomised, stepped-wedge trial assessing effectiveness of the revised versus original Ryan White Part A HIV Care Coordination Programme for patients with barriers to treatment in the USA.
BMJ Open. 2020 Jul 27;10(7):e034624. doi: 10.1136/bmjopen-2019-034624.
3
Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history.
Harm Reduct J. 2019 Sep 2;16(1):53. doi: 10.1186/s12954-019-0326-2.
4
How to Evolve the Response to the Global HIV Epidemic With New Metrics and Targets Based on Pre-Treatment CD4 Counts.
Curr HIV/AIDS Rep. 2019 Aug;16(4):304-313. doi: 10.1007/s11904-019-00452-7.
5
Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
Drug Alcohol Depend. 2018 Nov 1;192:74-79. doi: 10.1016/j.drugalcdep.2018.07.034. Epub 2018 Sep 12.
6
Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
PLoS One. 2018 Mar 29;13(3):e0194799. doi: 10.1371/journal.pone.0194799. eCollection 2018.
7
Trends in predictors of death due to HIV-related causes among persons living with AIDS in New York City: 1993-2001.
J Urban Health. 2005 Dec;82(4):584-600. doi: 10.1093/jurban/jti123. Epub 2005 Oct 19.
本文引用的文献
1
Economic and geographic diversity in AIDS incidence among HIV exposure groups in New York City: 1983 to 1995.
AIDS Public Policy J. 1998 Fall;13(3):103-14.
2
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.
Am J Public Health. 2000 Mar;90(3):352-9. doi: 10.2105/ajph.90.3.352.
3
Declining HIV/AIDS mortality in New York City.
J Acquir Immune Defic Syndr. 1999 May 1;21(1):59-64. doi: 10.1097/00126334-199905010-00008.
4
New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.
JAMA. 1998 Jul 1;280(1):42-8. doi: 10.1001/jama.280.1.42.
5
Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.
JAMA. 1998 Feb 11;279(6):450-4. doi: 10.1001/jama.279.6.450.
6
The completeness of AIDS case reporting in New York City.
JAMA. 1993 Jun 16;269(23):2995-3001.
7
Trends in the first ten years of AIDS in New York City. The New York City Department of Health AIDS Surveillance Team.
Am J Epidemiol. 1993 Jan 15;137(2):121-33. doi: 10.1093/oxfordjournals.aje.a116652.
8
Trends in transfusion-associated acquired immune deficiency syndrome in the United States, 1982 through 1991.
Transfusion. 1993 Nov-Dec;33(11):890-3. doi: 10.1046/j.1537-2995.1993.331194082377.x.
9
Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team.
N Engl J Med. 1994 Nov 24;331(21):1422-7. doi: 10.1056/NEJM199411243312106.
10
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
N Engl J Med. 1994 Nov 3;331(18):1173-80. doi: 10.1056/NEJM199411033311801.
Zotero 插件